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Abstract
Cardiovascular variabilities were recognized over 250 years ago, but only in the past 20 years has their apparent
utility come to be appreciated. Technological advancement has allowed precise measurement and quantification
of short-term cardiovascular fluctuations; however, our understanding of the integrated mechanisms which underlie
these oscillations is inadequate for their widespread application. Both autonomic branches, the parasympathetic
and sympathetic nervous system, are key determinants of the magnitude of these spontaneous cardiovascular
fluctuations. Heart rate variability can be an indicator of an individual cardiovascular condition. In this review, we
will discuss the two primary rhythmic oscillations that underlie the complexity of the heart rate waveform. The first
oscillation occurs over several cardiac cycles, is respiratory related, and termed respiratory sinus arrhythmia. The
second oscillation occurs at an approximate 10 s cycle. Due to the closed-loop nature of the control system of
cardiovascular oscillations, it is difficult to define specific relations among cardiovascular variables. In this review, we
will present the feedforward and feedback mechanism that underlie both oscillations and their implication as
quantitative measures of autonomic circulatory control. We will also review the various methodologies to assess
them.
Keywords: Heart rate variability, Respiratory sinus arrhythmia, Mayer waves, Autonomic control, Cardiovascular
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Background
Variability in beat-by-beat heart period is an intrinsic
characteristic of healthy cardiac functioning. This vari-
ability can reflect purposely generated responses to in-
ternal and external stimuli and may not reflect simple
random fluctuations. For example, various stressors re-
sult in characteristic changes in variability and various
disease states are associated with lesser variability. The
primary regulators of cardiac chronotropy, the parasym-
pathetic and sympathetic nervous systems, are key deter-
minants of the magnitude of spontaneous cardiovascular
variability. In this review, we will focus on two primary
rhythmic oscillations occurring at the respiratory fre-
quency and at the ~0.10 Hz frequency since these two
have the greatest importance for human cardiovascular
control. Moreover, these cardiovascular variabilities have
been most studied and most often used to index auto-
nomic circulatory control.
Physiological basis
Cardiac chronotropy can be represented in two ways.
Representation of cardiac chronotropy by heart rate
(HR) as beats per minute (bpm) has a long history be-
cause it is readily and easily accessible by simple palpa-
tion of an artery. However, HR provides an estimate that
is normalized to time (i.e., 60 s). With the development
of the electrocardiogram (ECG), physiologists were able
to minutely assess the time interval between beats in
milliseconds. In fact, this linear measure of cardiac
chronotropy better reflects its autonomic regulators. The
interval between R waves in the ECG (RRi) is most com-
monly used and reflects a linear relationship to both para-
sympathetic (vagal) and sympathetic stimulation [1, 2].
Given that HR is the inverse of RRi, fluctuations in the
two do not always conform to one another (Fig. 1). Hence,
heart rate variability should not be used as anything more
than a misnomer and instead RRi variability should be
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used. In this review, out of convenience and convention,
we will use the widely adopted term heart rate variability
(HRV) to discuss the physiology and measurement of RRi
variability.
Fluctuations in heart rate are usually due to waxing
and waning activity level in at least one arm of the auto-
nomic nervous system (ANS). Under normal conditions,
the chronotropic state of the heart is entirely regulated
by the sinoatrial (SA) node. The SA node is directly in-
nervated by both parasympathetic (vagal) and sympa-
thetic efferents. Although both vagal and sympathetic
nerves exert opposite chronotropic action on the heart,
these effects are not symmetrical [2–4]. Vagal effects
have a distinctly shorter latency than sympathetic effects.
Vagally mediated RRi lengthening is mediated by synap-
tic release of acetylcholine (ACh). The response is al-
most immediate due to the very short effect latency and
high turnover rate of ACh, allowing the parasympathetic
system to exert cardiac control on a beat-by-beat basis
[5]. Sympathetically mediated RRi shortening is medi-
ated by synaptic release of noradrenaline which is reab-
sorbed and metabolized relatively slowly [5]. This results
in a delay between the onset of sympathetic stimulation
and the resultant changes in cardiac control. Hence, the
effect of sympathetic nerves on RRi encompasses longer
delays and potentially longer effects than parasympa-
thetic nerves.
The characteristic delay and duration of the two auto-
nomic arms result in different potential effects on HRV.
That is, the faster vagal effects have the potential to act
across a wide range of frequencies, from a single beat to
many beats, whereas the sympathetic system may not.
However, time domain quantification of HRV cannot
discriminate frequency-specific effects. These can only
provide global indexes for HRV. Frequency domain ana-
lysis can assess HRV across frequency components while
ignoring random, non-rhythmic noise. While time do-
main is simple and global, the frequency domain elimi-
nates noise and allows for easy differentiation of the two
primary rhythmic oscillations contained in HRV. Hence,
spectral analysis of HRV is the most precise and most
widely used technique to assess specific rhythms that
exist in the HRV. The majority of the data discussed
below derives from frequency domain information.
Respiratory frequency oscillations
Respiratory sinus arrhythmia (RSA) is a rhythmic heart
rate oscillation at the respiratory frequency and can be
quantitatively measured as a high-frequency component
(usually >0.15 Hz) in the power spectrum of RRi. RSA is
a widely studied physiological phenomenon that reflects
numerous cardiorespiratory interactions. RSA is typically
characterized by RRi shortening with inspiration and
lengthening with expiration. The magnitude of RSA is
thought to reflect the degree of respiratory modulation
of vagal outflow and arises from complex interactions of
both central and peripheral factors.
One possible driving mechanism for RSA is the re-
sponse of RRi to arterial pressure fluctuations. During
breathing, changes in intrathoracic pressure rhythmically
alter venous return to the heart, thereby impacting cardiac
output and subsequently changing arterial blood pressure.
These arterial pressure changes engage the arterial barore-
flex, generating oscillations in afferent activity to appropri-
ately increase and decrease cardiac autonomic outflow,
generating RSA. Indeed, in humans, respiration frequency
and depth can strongly determine fluctuation amplitude
[6–8]. The magnitude of RSA increases with increased
tidal volume and decreased breathing frequency. It has
been suggested that the magnitude of RSA might be due
to respiratory changes in systolic blood pressure due to
tidal volume and breathing frequency. Hence, it has been
hypothesized that RSA represents baroreflex buffering of
arterial blood pressure fluctuations induced by the mech-
anical effects of breathing.
If that were the case, eliminating RRi fluctuations, and
hence RSA, should result in increased respiratory related
arterial pressure fluctuations. However, in young individ-
uals, elimination of RSA via complete autonomic blockade
decreased arterial pressure fluctuations in the supine pos-
ition, and it increased them in only the upright position [9].
These findings are further supported by elimination of RSA
through fixed-rate atrial pacing. Atrial pacing decreased
respiratory-related arterial pressure oscillations in the su-
pine position, but increased them in the upright position
(Fig. 2) [10]. In addition, it is apparent that RSA does not
subserve a role in stabilizing diastolic pressure in supine
humans. Progressive increases and decreases of RSA via
low doses of the parasympatholytic agent atropine results
in parallel and proportional increases and decreases in
Fig. 1 Relationship between heart rate (HR) and R-R interval (RRi).
Note the hyperbolic behavior of HR (bpm) as a function of RRi (ms);
same increase in RRi (ΔRRi = 100 ms) results in markedly different
changes in HR (ΔHR) according to the chronotropic RRi
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diastolic pressure oscillations at the respiratory frequency
[11]. Hence, it seems that RSA contributes to arterial pres-
sure oscillations in supine humans. Moreover, the postural
differences can be explained by the shift in the phase rela-
tionship between RRi and systolic pressure oscillations. In
the supine position, RRi oscillations are in phase with those
in arterial pressure, but in the upright position, RRi oscilla-
tions follow those in arterial pressure [12]. This suggests
that the arterial baroreflex is one important mechanism
underlying RSA in upright but not supine humans. This
could be due to the large caudal shift in blood volume con-
sequent to assuming the upright posture that requires ac-
tive and persistent baroreflex engagement to control
arterial pressure [13].
However, baroreflex engagement does not explain the
presence of RSA in supine humans. It is known that gating
of excitatory input to the vagal cardiomotor neurons
(CVM) partially contributes to RSA [14–16]. Data from
animal models show CVM activity linked to the central
respiratory cycle. While CVM activity in rats is greatest
during inspiration [17], in cats, dogs, and humans, CVM
are inhibited during inspiration and are mildly activated
during expiration by stimulation of the arterial chemore-
ceptors and baroreceptors [18–20]. Thus, the susceptibil-
ity of CVM varies systematically during the respiratory
cycle, and it is possible that RSA could arise from an effer-
ent vagal oscillation that contributes to arterial pressure
fluctuations by gating the excitatory input to the vagal
motor neurons [3, 21]. The neural networks generating re-
spiratory activity could not only drive respiratory motor
neurons, but also impose patterns of activity in the vagal
and sympathetic outflows. Functionally, this may provide
a mechanism for the integration of cardiovascular and re-
spiratory control [20].
Respiratory sinus arrhythmia is frequently used as an
index of cardiac vagal tone or is even believed to be a
direct measure of vagal tone. Substantial published data
suggests that RSA quantifies tonic cardiac vagal activity
[2, 22–26]. Despite physiological studies questioning re-
spiratory sinus arrhythmia as a valid and reliable cardiac
parasympathetic index [4, 27], numerous clinicians and
experimentalists routinely estimate vagus nerve traffic to
the heart with measurements of RSA. However, even
though vagal outflow is the key contributor to HRV,
there are significant caveats regarding the assumption
that RSA is mediated exclusively by vagal mechanisms.
Observations that β-blockers augment RSA have been
interpreted as indicating a central vagomimetic effect for
these drugs [28, 29]. However, the data may actually sug-
gest that sympathetic activity opposes vagally mediated
RRi oscillations. This would mean that differences in
RSA could not solely be ascribed to differences in vagal
outflow. For example, β-adrenergic blocking drugs that
do and do not cross the blood-brain barrier equally re-
sult in increased RSA [30]. Moreover, enhancement of
RRi oscillations via cardioselective β-adrenergic blockade
is exerted across a wide range of frequencies, from very
low to high breathing frequencies [31]. If the delay and
duration of sympathetic nervous effects constrain their
impact to lower frequencies (<0.15 Hz), then cardiac
sympathetic blockade should not impact variability
across all frequencies. Moreover, in young healthy indi-
viduals, as vagal tone decreases during mild exercise, sig-
nificant RSA can be generated by non-neural factors
[32]. In dogs, direct cardiac vagus nerve stimulation that
increases HRV does not result in a quantitative relation-
ship between the frequency of vagal stimulation and
HRV [33]. These results suggest that changes in HRV
Fig. 2 R-R interval and systolic pressure power in young individuals in the supine position and 40° tilt position with and without atrial pacing;
elimination of RSA through fixed atrial pacing decreases pressure oscillations at the respiratory frequency in the supine position, but increases
them in the upright position (redrawn from) [10]
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may not linearly reflect the vagally mediated chronotro-
pic response and challenge the assumption that RSA is
always a purely vagal mechanism.
Low-frequency oscillations
Heart rate variability at frequencies slower than respir-
ation in humans appear to occur in synchrony with ar-
terial pressure Mayer waves, at frequencies as low as
0.03 Hz and up to 0.15 Hz, but generally close to
0.10 Hz, corresponding to a 10 s rhythm. Mayer waves
result from an oscillation of sympathetic vasomotor tone
[34–36]. Their amplitude has been presumed to measure
vascular sympathetic activity since they are most appar-
ent in response to sympathoexcitatory stimuli and are
strongly attenuated or even abolished after acute α-
adrenoceptor blockade [37–40]. However, these initial
observations are not sufficient to capture the complex
interactions that underlay the mechanism of Mayer wave
oscillations.
Evidence suggests that the arterial baroreflex may be
an essential component for sympathetic oscillations
[12, 35, 36] and that Mayer waves are dependent upon
intact arterial baroreflex function. The arterial baro-
receptor reflex is the fastest and the most powerful
regulator of blood pressure [41]. Thus, it has been pro-
posed that Mayer wave oscillations could be caused by
a time delay in the sympathetic feedback loop of the
baroreflex [12, 42].
In healthy individuals, monotonic atrial pacing in su-
pine eliminates RRi variability, but does not affect low
frequency arterial pressure oscillations (Fig. 2) [10].
This shows that elimination of RRi variability does not
increase low-frequency arterial pressure oscillations.
However, when vascular sympathetic outflow is in-
creased by 40° tilt, elimination of low-frequency RRi
variability resulted in greater diastolic pressure Mayer
waves [10]. Thus, low-frequency RRi oscillations appear
to buffer low-frequency arterial pressure oscillations
only in upright humans. Hence, this might mean that a
sympathetic mechanism is responsible, perhaps a la-
tency in baroreflex-induced changes in vascular sympa-
thetic outflow, in other words, a pressure-pressure
feedback loop [43]. Thus, this supports the hypothesis
that there is an arterial baroreflex link between Mayer
wave oscillations in pressure and cardiac interval when
sympathetic outflow is augmented. However, there is
no simple linear relationship between Mayer wave
amplitude and mean sympathetic outflow. Healthy indi-
viduals with different sympathetic outflow show no dif-
ference in Mayer wave amplitude; despite striking
differences in resting sympathetic outflow, similar
Mayer wave amplitudes were observed in older healthy
males and young females (Fig. 3) [44].
Also, artificial augmentation of low-frequency pressure
oscillations revealed a highly variable relationship be-
tween arterial pressure and cardiac interval fluctuations
[45]. The increase in Mayer wave oscillations from
Fig. 3 Relationship between vascular sympathetic outflow and Mayer wave amplitude in systolic (a) and diastolic pressure (b); despite striking
differences in resting sympathetic outflow, older healthy males and young females show similar Mayer wave amplitudes (redrawn from [44]).
aiu arbitrary integration units
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graded forced oscillations support the implication of ar-
terial baroreflex engagement. However, the strength of
the cross-spectral coherence between low-frequency os-
cillations was highly unstable, within and among sub-
jects, and across levels of forced oscillations. This
indicates that heart period oscillations do not buffer
pressure consistently through the baroreflex. Hence,
even though baroreflex gain represents an important
mechanism for cardiovascular oscillations at the Mayer
wave frequency, other factors might also be involved.
Measurement of heart rate variability
Changes in RRi defined as HRV indicate a normal re-
sponse of the heart to multiple physiological and envir-
onmental stimuli such as breathing, physical exercise,
mental stress, hemodynamic alterations, and metabolic
changes [46, 47]. One way of understanding HRV is con-
sidering the variance with respect to the mean, i.e., a
measure of the spread of the distribution. The fluctua-
tions occur either in a random pattern (noise) or exhibit
deterministic variations. As described above, changes in
RRi reflect autonomic modulation and provide a sensi-
tive and early indicator of health impairments. While
high HRV is associated with efficient autonomic mecha-
nisms in healthy individuals, low HRV is an indicator of
abnormal and inadequate adaptations of the ANS and,
in some cases, increased mortality and morbidity. Thus,
HRV has been identified as a promising marker to study
autonomic function and to diagnose pathological states,
both in research and clinical setups. A range of indexes
have been derived from fluctuations not just in heart
period but also in blood pressure, sympathetic nerve ac-
tivity, blood flow, “spontaneous” bareoreflex sensitivity,
and cerebral "autoregulation". However, the significance
and meaning of HRV is more complex than generally
appreciated and careful examinations should be consid-
ered in measuring and interpreting it. Quantitative ap-
proaches in assessing HRV include linear methods, time
domain, frequency domain, and nonlinear methods.
Electrocardiograms of variable durations have been
used to assess HRV. In a continuous ECG record, the P
wave representing the atrial contraction is the electrical
signal that initiates a beat. The impulse is conducted
through the atrioventricular node via the Purkinje fibers,
leading to depolarization of the ventricles, which is rep-
resented by the Q, R, and S waves, forming the QRS
complex in the ECG. Afterwards, the ventricular repolar-
ization follows, represented by the T wave. During the R
phase, most of the heart is activated resulting in the
greatest wave shown by the ECG recording. Thus, most
studies of cardiovascular variabilities use indexes of car-
diac chronotropic response derived from the R wave in
the QRS complex since it is easiest to detect. Heart rate
variability indexes are obtained by analyzing the
variation between beat-by-beat intervals measured
between consecutive QRS complexes, conventionally
named RRi. For assessing HRV, initial filtering methods
are used to discard premature ectopic beats or artifacts,
by detecting and correcting abnormal RRi.
Linear methods
Time domain
In the time domain, indexes of HRV are expressed in
unit time (ms). Statistical or geometrical methods (i.e.,
mean, standard deviation, and histogram-derived in-
dexes) are used to assess fluctuations in the cardiac cycle
from the inherently discrete and uneven time series.
Statistical analysis of RRi in the time domain includes
several indexes. The most routine measurements of
HRV consider the mean of RRi for normal beats (mean
RRi, in ms) and the standard deviation of all normal RRi
(SDNN, in ms) recorded in a time interval. Other HRV
indexes in the time domain include standard deviation
of the means of RRi (SDANN, in ms), mean of the 5-
min standard deviations of RRi (SDNNi, in ms), root-
mean square of differences between adjacent normal RRi
(rMSSD, in ms), and percentage of adjacent RRi with a
difference of duration greater than 50 ms (pNN50).
The SDNN, SDANN, and SDNNi indexes are usually
obtained from long-term recordings. About 30–40 %
of the SDNN magnitude is attributed to day:night dif-
ferences in RRi, and thus, long-term recordings of at
least 18 h of data are required for accurate assessment
[48, 49]. Correct calculation of these indexes require
careful considerations, excluding ectopic beats, arti-
facts, and missed beats. These indexes can be used to
assess autonomic nervous system activity; however,
they cannot distinguish between changes in HRV due
to increased sympathetic tone or withdrawal of vagal
tone. The rMSSD and pNN50 indexes primarily quan-
tify modulation of RRi driven by ventilation.
Frequency domain
Autoregressive models and the Fast Fourier Transform
(FFT) are used to quantify cyclic fluctuations of RRi.
Frequency domain analysis decomposes HRV into four
fundamental oscillatory components seen as four peaks
in the power spectra obtained using the FFT method.
The high-frequency component (HF) represents a peak
ranging between 0.15 and 0.40 Hz in the power spectra.
As discussed above, the HF component usually reflects
RSA, mostly due to vagal activity. Low frequency (LF)
components range between 0.04 and 0.15 Hz (Mayer
wave oscillations), occur over a period of 10 s, and are
due to both sympathetic and parasympathetic control.
The very low frequency (VLF) component ranges be-
tween 0.0033 and 0.04 Hz, or periods of 20 s to 5 min.
The ultra-low frequency (ULF) component is associated
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with frequencies less than 0.003 Hz, with periods be-
tween 5 min and once during 24 h. The exact physio-
logical mechanisms responsible for VLF and ULF are
not yet established, but they may relate to the renin-
angiotensin-aldeosterone system, thermoregulation, and/
or peripheral vasomotor tone.
Further attempts to understand the complex mecha-
nisms that underlie HRV include the use of the ratio of
the high- and low-frequency oscillations (LF/HF) and/or
the normalization of these two oscillations to total vari-
ability. The ratio of high- and low-frequency oscillations
LF/HF is assumed to reflect the absolute and relative
changes between the sympathetic and parasympathetic
components. Normalization of the two oscillations is ob-
tained by dividing the power of one of the components
by the total power spectrum, and subtracting the VLF
component. The conclusions derived from HRV when
using normalized units and/or LF/HF ratio should be
carefully reconsidered. The underlying assumption in
using either normalized units and/or LF/HF ratio is that
there is a sympathovagal balance that modulates the
sinus node activity (i.e., increased activity in one system
is accompanied by decreased activity in the other sys-
tem). Support derives, in part, from the correlations be-
tween passive tilt angle in humans and normalized
variability and the LF/HF ratio [50]. However, this recip-
rocal relationship between parasympathetic and sympa-
thetic outflows does not apply to all conditions. For
example, while only parasympathetic withdrawal occurs
at low exercise intensities, both further parasympathetic
withdrawal and sympathetic activation occur at moder-
ate and higher exercise intensities in humans [51].
Moreover, normalizing variability data results in a
change in total power (the denominator of the
normalization) that can introduce artifactual changes
and can lead to erroneous conclusion about the physi-
ology of HRV. For example, high doses of atropine are
parasympatholytic, markedly increasing heart rate and
decreasing HRV. However, normalized units of variabil-
ity indicate that significant oscillations still remain des-
pite a nearly monotonic heart rate [52]. Nonetheless,
when performed judiciously, spectral analysis can yield
important insights, including delimiting frequency re-
sponses of the cardiovascular system, and potential
cause relations among cardiovascular and respiratory
variables.
Non-linear methods
Non-linear phenomena are certainly involved in the gen-
esis of HRV. The dynamic nature of HRV may not be
properly appreciated by linear methods. As a result, the-
ories of non-linear systems have been proposed as
unique identifiers of the complex interactions of the nu-
merous mechanisms that modulate variability in heart
period. Hence, fractal mathematics and chaotic dynamics
have been applied to HRV. The underlying assumption
behind these techniques is that the individual behavior
and dynamics observed represent the behavior of the
overall system, independent of a characteristic time or
length scale of operation. In healthy individuals, heart
rate is neither constant nor strictly periodic. Instead,
beat-to-beat HRV demonstrates an apparent chaotic pat-
tern of fluctuations in healthy subjects. Time- and
frequency-domain analysis of beat-to-beat heart rate os-
cillations show that these fluctuations could be chaotic
in nature [53, 54]. Thus, it has been suggested that frac-
tal measures of beat-to-beat time series of heart period
could describe the integrated control of HRV independ-
ent of time or frequency scale [55, 56]. However, by def-
inition, heart beats are discrete events, and thus, the
resolution of the structure is limited and cannot be
smaller than the shortest interval between consecutive
beats. To correctly establish fractal behavior of a struc-
ture, the current literature suggests that large data series
are necessary (at least 20 min) to allow reliable calcula-
tions of a single fractal scaling exponent [57, 58]. Even
when some conditions are met to assume fractal behav-
ior (such as a strong power-law scaling), a majority of
heart period time series in healthy individuals do not
conform to the assumed standard fractal model and thus
cannot be considered fractal processes [59]. Moreover,
the most relevant fluctuations in heart rate period occur
around 6 s or faster (respiratory sinus arrhythmia, pri-
marily related to vagal control) or around 10 s (Mayer
wave oscillations, reflecting both sympathetic and para-
sympathetic control). Even when heart rate time series
assume fractal behavior, given the restricted temporal
range of heart rate fluctuations, it is important to assess
the physiological meaning obtained from fractal analysis
and their relevance to cardiac autonomic control. Thus,
careful considerations should be made when using frac-
tal estimates as the results might not reflect true changes
in alterations within individuals, or they might produce
physiologically meaningless and irreproducible values.
Conclusions
Heart rate dynamically responds to internal and external
perturbations on a beat-by-beat basis. The complexity of
the heart rate time series has within it cardiovascular os-
cillations occurring at specific frequencies. However, the
closed-loop nature of the control of these cardiovascular
oscillations makes it difficult to define specific relations
among autonomic variables. Both respiratory frequency
oscillations (RSA) and slower oscillations at the Mayer
wave frequency have been attributed to various feed-
forward and feedback mechanisms. Nonetheless, work in
the area of cardiovascular variabilities has attempted to
derive indexes for autonomic outflow from fluctuations in
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heart period and blood pressure. In particular, RSA has
become a popular metric for autonomic control and is
presumed by many investigators to have a one-to-one cor-
respondence to cardiac vagal outflow. Even though vagal
outflow is the dominant contributor to RSA, several ob-
servations presented in this review challenge the assump-
tion that RSA is always a purely vagal mechanism or
corresponds proportionately to vagal outflow. As with re-
spiratory frequency oscillations, Mayer wave frequency
variability has been presumed to represent a sympathetic
effect on the heart. However, the exact relation between
mean sympathetic outflow and Mayer wave amplitude is
still unclear and it appears that cardiovascular oscillations
at the Mayer wave frequency may be generated by mecha-
nisms other than sympathetically mediated. Hence, the
understanding of the integrated mechanisms that underlie
these cardiovascular oscillations is still largely unknown
and it is likely that they represent complex interactions of
several effectors. Moreover, the measurement and quanti-
fication of these cardiovascular variabilities should be judi-
ciously performed to yield meaningful physiological
insights. Thus, given the complex nature of cardiovascular
variabilities, careful consideration should be given when
attempting to use them as quantitative measures of auto-
nomic outflow or as clinical indexes of individual cardio-
vascular condition.
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